A Reply to ‘‘Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver”
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- MITF—the first 25 yearsGenes & Development, 2019
- Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell LinesCell Reports, 2017
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinomaNature Genetics, 2016
- Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificityNature Biotechnology, 2015
- Src promotes GTPase activity of Ras via tyrosine 32 phosphorylationProceedings of the National Academy of Sciences, 2014
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor–Negative Melanoma CellsCancer Research, 2008
- Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanomaNature, 2005
- The G11 Gene Located in the Major Histocompatibility Complex Encodes a Novel Nuclear Serine/Threonine Protein KinaseJournal of Biological Chemistry, 1998
- Regulation of tyrosinase in human melanocytes grown in culture.Journal of Cell Biology, 1983